Formulation | Marketed product |
Nicotine transdermal patches | 5 mg, 10 mg, 15 mg/16 h (Nicorette®, Pfizer) |
| 7 mg, 14 mg, 21 mg/24 h (Nicotnell® TTS 10, TTS 20, TTS 30, Novartis) |
| 7 mg, 14 mg. 21 mg/24 h (NiQuitin® CQ, GSK) |
Nicotine chewing gum | 2 mg, 4 mg (Nicorette®, Pfizer; Nicotinell®, Novartis) |
Nicotine oral tablets | 2 mg sublingual tablet (Nicorette® Microtab®, Pfizer) |
| 1 mg lozenge (Nicotinell®, Novartis) |
| 2 mg and 4 mg lozenge (NiQuitin® CQ, GSK) |
Nicotine “oral” inhaler | 10 mg inhalation cartridge, plus mouthpiece (Nicorette® Inhalator, Pfizer) |
Nicotine nasal spray | 0.5 mg per spray into each nostril (Nicorette® Nasal Spray, Pfizer) |